Company News in the Life Science Industry

»

Reset 

Three Squared Adapts Residential Shipping Containers to Help End COVID-19 Hospital Housing Shortage

DETROIT, March 29, 2020 /PRNewswire/ -- Amid throngs of daily reports lamenting the critical lack of hospital beds and similar space shortage... Read more ››

By: PR Newswire Association LLC. - 29 Mar 2020

University of South Florida Health, Northwell Health, Formlabs and Tampa General Hospital Join Forces to Create 3D Printed Nasal Swabs to Test for COVID-19 in Patients in Emergency Shortage Situations

TAMPA, Fla. and SOMERVILLE, Mass. and NEW HYDE PARK, N.Y., March 28, 2020 /PRNewswire/ -- The University of South Florida (USF) Health, Formlabs,... Read more ››

By: PR Newswire Association LLC. - 29 Mar 2020

Mayors to President Trump: Help Us Secure Critical Covid-19 Emergency Equipment

WASHINGTON, March 28, 2020 /PRNewswire/ -- Today, the leadership of the U.S. Conference of Mayors (USCM) sent a letter to President Donald J. Trump asking for help in securing critical supplies and equipment needed to safeguard first responders and healthcare workers in cities across the country.

... Read more ››
By: PR Newswire Association LLC. - 28 Mar 2020

Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products

SILVER SPRING, Md., March 28, 2020 /PRNewswire/ -- During this COVID-19 pandemic, the FDA is working around the clock to make sure that Americans have access to safe food and medical products. The agency is continuously examining the global supply chain to identify any concerns and assess the... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  U.S. Food and Drug Administration

Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Read more ››
By: GlobenewsWire - 28 Mar 2020
Related companies:  Novan, Inc.

Ryvu Therapeutics Receives Orphan Drug Designation From FDA for SEL120 to Treat Acute Myeloid Leukemia

KRAKOW, Poland, March 28, 2020 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted an orphan drug... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020

Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19

IRVINE, Calif., March 28, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it will temporarily pause new enrollments in its active pivotal clinical trials... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  Edwards Lifesciences Corp.

Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol

THOUSAND OAKS, Calif., March 28, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  Amgen, Inc.

Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization

RARITAN, N.J., March 28, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO(®) (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  Johnson & Johnson

Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

EAST HANOVER, N.J., March 28, 2020 /PRNewswire/ -- Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  Novartis Pharmaceuticals Corporation

CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC

Read more ››
By: GlobenewsWire - 28 Mar 2020

Latin American Healthcare Systems, 2020: The Impact of COVID-19 -- Health Ministries Have Differentiated Policy Reactions

DUBLIN, March 27, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020

Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes

ABBOTT PARK, Ill., March 27, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  Abbott Laboratories

ChatBunker announces FREE customizable HIPAA compliant communication platform / Responsible Professional Media (RPM)

BERKELEY, Calif., March 27, 2020 /PRNewswire/ -- COVID-19 has caused healthcare systems to restructure its workforce. Team members, ancillary support and personnel will be forced to share patient information in an unprecedented manner. ChatBunker breaks down barriers of communication that obstruct... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020

Denver Mattress Company is now manufacturing face masks by the thousands to help in the fight against COVID-19

DENVER, March 27, 2020 /PRNewswire/ -- Denver Mattress Company has restructured its manufacturing facility to begin production of face masks to assist healthcare facilities and others across the country in the fight against COVID-19. Production began on March 26, 2020, and in only two days thousands... Read more ››

By: PR Newswire Association LLC. - 28 Mar 2020

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., March 27, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 28 Mar 2020
Related companies:  U.S. Food and Drug Administration

Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetings

Read more ››
By: GlobenewsWire - 27 Mar 2020
Related companies:  Galapagos NV

electroCore Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital

Read more ››
By: GlobenewsWire - 27 Mar 2020
Related companies:  electroCore LLC

PDS Biotechnology Reports Full Year 2019 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 27 Mar 2020
Related companies:  PDS Biotechnology Corporation

Cubii’s Free Virtual Exercise Classes Help Participants Stay Active During Shelter-in-Place

Read more ››
By: GlobenewsWire - 27 Mar 2020
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies